The Economic and Humanistic Burden of Severe Sepsis

PharmacoEconomics

Volumn 33, Issue 9, 2015, Pages 925-937

  Tiru, Bogdan ^a,b   DiNino, Ernest K ^a,b   Orenstein, Abigail ^a,b   Mailloux, Patrick T ^a,b   Pesaturo, Adam ^b   Gupta, Abhinav ^b   McGee, William T ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAREGIVER; CHRONIC DISEASE; DEVELOPED COUNTRY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MEDICAL LITERATURE; MEDICAL SUBJECT HEADINGS; MEDLINE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEPSIS; SEPTIC SHOCK; SHOCK; COST OF ILLNESS; DRUG UTILIZATION; ECONOMICS; HEALTH SERVICE; INCIDENCE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

COST OF ILLNESS; DRUG UTILIZATION; HEALTH SERVICES; HUMANS; INCIDENCE; LENGTH OF STAY; MODELS, ECONOMETRIC; QUALITY OF LIFE; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84941023356     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-015-0282-y     Document Type: Review

References (97)

1. Adhikari NKJ, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. The Lancet. 2010;376(9749):1339–46.
2. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–9.
3. Azoulay E, Alberti C, Legendre I, Buisson CB, Le Gall JR. Post-ICU mortality in critically ill infected patients: an international study. Intensive Care Med. 2005;31(1):56–63.
4. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–74.
5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.
6. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244–50.
7. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Eng J Med. 2003;348(16):1546–54.
8. Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35(8):1928–36.
9. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40(3):754–61.
10. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311(13):1308–16.
11. Vincent J-L, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53.
12. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–24.
13. Reade MC, Yende S, D’Angelo G, Kong L, Kellum JA, Barnato AE, et al. Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med. 2009;37(5):1655–62.
14. Yang Y, Yang KS, Hsann YM, Lim V, Ong BC. The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis. J Crit Care. 2010;25(3):398–405.
15. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis*. Crit Care Med. 2006;34(1):15–21.
16. Hodgin KE, Moss M. The epidemiology of sepsis. Curr Pharm Des. 2008;14(19):1833–9.
17. Patel PR, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients. Am J Kidney Dis Off J Nat Kidney Found. 2010;56(3):566–77.
18. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis Off J Nat Kidney Found. 2013;61(1 Suppl 1):A7, e1–476.
19. Klevens RM, Edwards JR, Andrus ML, Peterson KD, Dudeck MA, Horan TC. Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial. 2008;21(1):24–8.
20. Kostakou E, Rovina N, Kyriakopoulou M, Koulouris NG, Koutsoukou A. Critically ill cancer patient in intensive care unit: issues that arise. J Crit Care. 2014;29(5):817–22.
21. Frere P, Baron F, Bonnet C, Hafraoui K, Pereira M, Willems E, et al. Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplant. 2006;37(4):411–8.
22. Bock AM, Cao Q, Ferrieri P, Young JA, Weisdorf DJ. Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2013;19(1):102–8.
23. Arulkumaran N, West S, Chan K, Templeton M, Taube D, Brett SJ. Long-term renal function and survival of renal transplant recipients admitted to the intensive care unit. Clin Transplant. 2012;26(1):E24–31.
24. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695–701.
25. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2013;14(7):686–93.
26. Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2005;6(3 Suppl):S3–5.
27. Czaja AS, Zimmerman JJ, Nathens AB. Readmission and late mortality after pediatric severe sepsis. Pediatrics. 2009;123(3):849–57.
28. Wolfler A, Silvani P, Musicco M, Antonelli M, Salvo I. Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey. Intensive Care Med. 2008;34(9):1690–7.
29. Skippen P, Kissoon N, Waller D, Northway T, Krahn G. Sepsis and septic shock: progress and future considerations. Indian J Pediatr. 2008;75(6):599–607.
30. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? where? why? Lancet. 2005;365(9462):891–900.
31. Acosta CD, Knight M, Lee HC, Kurinczuk JJ, Gould JB, Lyndon A. The continuum of maternal sepsis severity: incidence and risk factors in a population-based cohort study. PloS One. 2013;8(7):e67175.
32. Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991–2003. Am J Obstet Gynecol. 2008;199(2):133 e1–8.
33. Torio CM (AHRQ) ARA. National inpatient hospital costs: the most expensive conditions by Payer, 2011. HCUP Statistical Brief #160.: Agency for Healthcare Research and Quality, Rockville, MD.; 2013 [cited 2014 September]. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb160.pdf. Accessed 23 Sept 2014.
34. Statistics UDoLBoL. [cited 2014 September]. Available from: http://www.bls.gov. Accessed 23 Sept 2014.
35. Hsu B, editor. Healthcare costs, resource use, and mortality rates for sepsis in teaching versus non-teaching hospitals. 2013 AAP National Conference and Exhibition; 2013: American Academy of Pediatrics.
36. (HCUP) HDHCaUP. Overview of the National (Nationwide) Inpatient Sample (NIS): Agency for Healthcare Research and Quality, Rockville, MD; 2014 [cited 2014 September]. Available from: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 23 Sept 2014.
37. Walkey AJ, Wiener RS. Hospital case volume and outcomes among patients hospitalized with severe sepsis. Am J Respir Crit Care Med. 2014;189(5):548–55.
38. Brun-Buisson C, Roudot-Thoraval F, Girou E, Grenier-Sennelier C, Durand-Zaleski I. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med. 2003;29(9):1464–71.
39. Adrie C, Alberti C, Chaix-Couturier C, Azoulay E, De Lassence A, Cohen Y, et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care. 2005;20(1):46–58.
40. Sznajder M, Leleu G, Buonamico G, Auvert B, Aegerter P, Merliere Y, et al. Estimation of direct cost and resource allocation in intensive care: correlation with Omega system. Intensive Care Med. 1998;24(6):582–9.
41. Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, et al. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care. 2007;11(3):R69.
42. Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care. 2004;8(5):R291–8.
43. Braun L, Riedel AA, Cooper LM. Severe sepsis in managed care: analysis of incidence, one-year mortality, and associated costs of care. J Manag Care Pharm JMCP. 2004;10(6):521–30.
44. Ernst FR, Malatestinic WN, Linde-Zwirble WT. Evaluating the clinical and financial impact of severe sepsis with Medicare or other administrative hospital data. Am J Health Syst Pharm AJHP Off J Am Soc Health Syst Pharm. 2006;63(6):575–81.
45. Sogayar AM, Machado FR, Rea-Neto A, Dornas A, Grion CM, Lobo SM, et al. A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units. Pharmacoeconomics. 2008;26(5):425–34.
46. Schmid A, Pugin J, Chevrolet JC, Marsch S, Ludwig S, Stocker R, et al. Burden of illness imposed by severe sepsis in Switzerland. Swiss Med Wkly. 2004;134(7–8):97–102.
47. Kaakeh R, Sweet BV, Reilly C, Bush C, DeLoach S, Higgins B, et al. Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm AJHP Off J Am Soc Health Syst Pharm. 2011;68(19):1811–9.
48. Fox ER, Birt A, James KB, Kokko H, Salverson S, Soflin DL. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm AJHP Off J Am Soc Health Syst Pharm. 2009;66(15):1399–406.
49. Blum RM, Stevens CA, Carter DM, Hussey AP, Marquis KA, Torbic H, et al. Implementation of a dexmedetomidine stewardship program at a tertiary academic medical center. Ann Pharmacother. 2013;47(11):1400–5.
50. Ho CK, Mabasa VH, Leung VW, Malyuk DL, Perrott JL. Assessment of clinical pharmacy interventions in the intensive care unit. Can J Hosp Pharm. 2013;66(4):212–8.
51. Aljbouri TM, Alkhawaldeh MS, Abu-Rumman AE, Hasan TA, Khattar HM, Abu-Oliem AS. Impact of clinical pharmacist on cost of drug therapy in the ICU. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2013;21(4):371–4.
52. Saokaew S, Maphanta S, Thangsomboon P. Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit. Pharm Pract. 2009;7(2):81–7.
53. Jiang SP, Zhu ZY, Wu XL, Lu XY, Zhang XG, Wu BH. Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study. Ther Clin Risk Manag. 2014;10:405–12.
54. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29(5):691–8.
55. Zaidi ST, Hassan Y, Postma MJ, Ng SH. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci PWS. 2003;25(6):299–302.
56. Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm AJHP Off J Am Soc Health Syst Pharm. 2007;64(23):2483–7.
57. Soguel L, Revelly JP, Schaller MD, Longchamp C, Berger MM. Energy deficit and length of hospital stay can be reduced by a two-step quality improvement of nutrition therapy: the intensive care unit dietitian can make the difference. Crit Care Med. 2012;40(2):412–9.
58. Merritt CL. Clinical imperative versus economic consequence: exploring the cost burden and opportunities in the care of patients with sepsis. Nurs Adm Q. 2011;35(1):61–7.
59. Nazer L, Al-Shaer M, Hawari F. Drug utilization pattern and cost for the treatment of severe sepsis and septic shock in critically ill cancer patients. Int J Clin Pharm. 2013;35(6):1245–50.
60. Burton T. Can hospitals afford not to prescribe Eli Lilly’s pricey sepsis drug Xigris? Wall Str J. 2001. http://www.wsj.com/articles/SB1000161406176046858. Accessed 20 Oct 2014.
61. Sanger-Katz M 2014 AHPSWFHCCISHTNYTRfhwn. The New York Times. 2014, 2 Aug 2014.
62. Holder AL, Huang DT. A dream deferred: the rise and fall of recombinant activated protein C. Crit Care. 2013;17(2):309.
63. Wenzel RP, Edmond MB. Septic shock—evaluating another failed treatment. N Eng J Med. 2012;366(22):2122–4.
64. Poole D, Bertolini G, Garattini S. Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis. Lancet Infect Dis. 2009;9(1):67–72.
65. Regalado A. To sell pricey drug, Eli Lilly fuels a debate over rationing. Wall Str J. 2003. http://www.wsj.com/articles/SB106382950695778600. Accessed 20 Oct 2014.
66. Cornes P. The economic pressures for biosimilar drug use in cancer medicine. Target Oncol. 2012;7(Suppl 1):S57–67.
67. Rosner F. Allocation or misallocation of limited medical resources. Cancer Investig. 2004;22(5):810–2.
68. Fojo T, Mailankody S, Lo A. Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1225–36.
69. Schmid A, Burchardi H, Clouth J, Schneider H. Burden of illness imposed by severe sepsis in Germany. Eur J Health Econ HEPAC Health Econ Prev Care. 2002;3(2):77–82.
70. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med. 2003;31(9):2316–23.
71. Lee H, Doig CJ, Ghali WA, Donaldson C, Johnson D, Manns B. Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med. 2004;32(4):981–5.
72. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. 2012;60(6):1070–7.
73. Sepsis Alliance. What is post-sepsis syndrome [cited 2014 September]. Available from: http://www.sepsisalliance.org/sepsis/post_sepsis_syndrome/. Accessed 26 Sept 2014.
74. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010;38(5):1276–83.
75. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA. 1997;277(13):1058–63.
76. Yende S, D’Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med. 2008;177(11):1242–7.
77. Myhren H, Ekeberg O, Stokland O. Health-related quality of life and return to work after critical illness in general intensive care unit patients: a 1-year follow-up study. Crit Care Med. 2010;38(7):1554–61.
78. Oeyen SG, Vandijck DM, Benoit DD, Annemans L, Decruyenaere JM. Quality of life after intensive care: a systematic review of the literature. Crit Care Med. 2010;38(12):2386–400.
79. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94.
80. Shah FA, Pike F, Alvarez K, Angus D, Newman AB, Lopez O, et al. Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med. 2013;188(5):586–92.
81. Granja C, Dias C, Costa-Pereira A, Sarmento A. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care. 2004;8(2):R91–8.
82. Hofhuis JG, Spronk PE, van Stel HF, Schrijvers AJ, Rommes JH, Bakker J. The impact of severe sepsis on health-related quality of life: a long-term follow-up study. Anesth Analg. 2008;107(6):1957–64.
83. Karlsson S, Ruokonen E, Varpula T, Ala-Kokko TI, Pettila V. Long-term outcome and quality-adjusted life years after severe sepsis. Crit Care Med. 2009;37(4):1268–74.
84. Davydow DS, Hough CL, Langa KM, Iwashyna TJ. Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2013;21(9):887–97.
85. Angus DC. The lingering consequences of sepsis: a hidden public health disaster? JAMA. 2010;304(16):1833–4.
86. Adelman RD, Tmanova LL, Delgado D, Dion S, Lachs MS. Caregiver burden: a clinical review. JAMA. 2014;311(10):1052–60.
87. Van Pelt DC, Schulz R, Chelluri L, Pinsky MR. Patient-specific, time-varying predictors of post-ICU informal caregiver burden: the caregiver outcomes after ICU discharge project. Chest. 2010;137(1):88–94.
88. Van Pelt DC, Milbrandt EB, Qin L, Weissfeld LA, Rotondi AJ, Schulz R, et al. Informal caregiver burden among survivors of prolonged mechanical ventilation. Am J Respir Crit Care Med. 2007;175(2):167–73.
89. Paratz JD, Kenardy J, Mitchell G, Comans T, Coyer F, Thomas P, et al. IMPOSE (IMProving Outcomes after Sepsis)—the effect of a multidisciplinary follow-up service on health-related quality of life in patients postsepsis syndromes—a double-blinded randomised controlled trial: protocol. BMJ Open. 2014;4(5):e004966.
90. Zampieri FG, Colombari F. The impact of performance status and comorbidities on the short-term prognosis of very elderly patients admitted to the ICU. BMC Anesthesiol. 2014;14:59.
91. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, et al. Comparison of two fluid-management strategies in acute lung injury. N Eng J Med. 2006;354(24):2564–75.
92. Raghunathan K, McGee WT, Higgins T. Importance of intravenous fluid dose and composition in surgical ICU patients. Curr Opin Crit Care. 2012;18(4):350–7.
93. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Eng J Med. 2000;342(18):1301–8.
94. Sevick MA, Bradham DD. Economic value of caregiver effort in maintaining long-term ventilator-assisted individuals at home. Heart Lung J Crit Care. 1997;26(2):148–57.
95. Hanly P, Ceilleachair AO, Skally M, O’Leary E, Kapur K, Fitzpatrick P, et al. How much does it cost to care for survivors of colorectal cancer? Caregiver’s time, travel and out-of-pocket costs. Support Care Cancer Off J Multinat Assoc Support Care Cancer. 2013;21(9):2583–92.
96. van den Berg B, Al M, van Exel J, Koopmanschap M, Brouwer W. Economic valuation of informal care: conjoint analysis applied in a heterogeneous population of informal caregivers. Value Health J Int Soc Pharmacoecon Outcomes Res. 2008;11(7):1041–50.
97. Prescott HC, Langa KM, Liu V, Escobar GJ, Iwashyna TJ. Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;190(1):62–9.